HOT AXIOS Gallbladder Drainage

EUS Therapeutics – Hot AXIOS

Hot AXIOS Innovative Technology

Hot Axios

The Hot AXIOS™ Stent and Electrocautery Enhanced Delivery System enables therapeutic endoscopists to access a symptomatic pancreatic pseudocyst, walled-off necrosis, gallbladder or bile duct via a transgastric or transduodenal approach to place the stent.

The system combines a cautery-enabled access catheter with the therapeutic Hot AXIOS™ Stent for a streamlined, exchange-free procedure.

The Hot AXIOS™ System is used under combined endoscopic and EUS guidance. Its electrocautery-enhanced delivery system is designed to facilitate smooth, efficient access into the target structure.

Over 400 endoscopists across Europe are already performing drainage procedures with LAMS for PFC/WON and have the ability to offer this novel procedure to non-surgical patients with acute cholecystitis who would previously have had to receive a percutaneous drain.1

Hot AXIOS Indications

Designed for precision and efficiency, the Hot AXIOS ™ Stent and Electrocautery-Enhanced Delivery System is transforming the landscape of minimally invasive procedures, offering unparalleled solutions for complex drainage needs.

The Hot AXIOS™ System is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of:

  • Gallbladder in patients with acute cholecystitis who are at high risk or unsuitable for surgery.
  • A pancreatic pseudocyst or a walled-off necrosis with ≥ 70% fluid content.
  • The bile duct after failed ERCP in patients with biliary obstruction due to a malignant stricture.

EUS Therapeutic offerings

Boston Scientific's EUS Therapeutic Solutions are making significant progress in addressing a broader range of complex diseases. The Hot AXIOS™ System allows it to support innovative treatment approaches across various gastrointestinal conditions that require precise and effective drainage solutions.

Hot AXIOS' adaptability in managing complex fluid collections and obstructions showcases its potential to transform therapeutic strategies across multiple clinical scenarios.

Explore our innovative therapies that bring new possibilities to patient care:

chronic

Chronic pancreatitis 

Approximately 5% to 16% of patients with acute pancreatitis and 20% to 40% of patients with chronic pancreatitis will develop pancreatic pseudocysts (PP)2 . Boston Scientific's EUS solutions offer innovative therapeutic approaches to manage this complex disease, enabling efficient and effective treatment procedures with our purpose-built drainage technology.​
Discover how we're transforming chronic pancreatitis care.

Learn more

acute chlolecystitis

Acute Cholecystitis

Acute cholecystitis is a complex gallbladder inflammation often requiring urgent intervention.
Boston Scientific's cutting-edge technologies provide innovative therapeutic options for managing acute cholecystitis, offering precise and minimally invasive procedures for patients at high risk or who are unsuitable for surgery.
Enhance your practice with our advanced solution for acute cholecystitis treatment with Hot AXIOS Stent.

Explore our solutions

Physician Resources

Connect With Us


References:

1. Data on file. Active accounts tracked through sales data.

2. Aghdassi et al, “Pancreatic pseudocysts – when and how to treat?” HPB 2006; 8: 432-441.​

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.

All images owned by Boston Scientific.

2025 Copyright © Boston Scientific Corporation or its affiliates. All rights reserved.